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Abstract
Enzymes often by far exceed the activity, selectivity, and sustainability achieved with
chemical catalysts. One of the main reasons for the lack of biocatalysis in the chemical
industry is the poor stability exhibited by many enzymes when exposed to process
conditions. This dilemma is exemplified in the usually very temperature‐sensitive
enzymes catalyzing the Baeyer–Villiger reaction, which display excellent stereo‐ and
regioselectivity and offer a green alternative to the commonly used, explosive
peracids. Here we describe a protein engineering approach applied to cyclohexanone
monooxygenase from Rhodococcus sp. HI‐31, a substrate‐promiscuous enzyme that
efficiently catalyzes the production of the nylon‐6 precursor ε‐caprolactone. We used
a framework for rapid enzyme stabilization by computational libraries (FRESCO),
which predicts protein‐stabilizing mutations. From 128 screened point mutants,
approximately half had a stabilizing effect, albeit mostly to a small degree. To
overcome incompatibility effects observed upon combining the best hits, an easy
shuffled library design strategy was devised. The most stable and highly active
mutant displayed an increase in unfolding temperature of 13°C and an approximately
33x increase in half‐life at 30°C. In contrast to the wild‐type enzyme, this
thermostable 8x mutant is an attractive biocatalyst for biotechnological applications.
K E YWORD S
Baeyer–Villiger monooxygenase, computational design, cyclohexanone, stabilization,
thermostability
1 | INTRODUCTION
The oxidation of ketones with peroxides and peracids is known as the
Baeyer–Villiger (BV) reaction, named after the scientists who
discovered it 120 years ago (Baeyer & Villiger, 1899). The credit for
the “invention” goes to nature, however, where mechanistically
analogously working enzymes called Baeyer–Villiger monooxygenases
(BVMOs) were presumably already present in the last universal
common ancestor (Mascotti, Lapadula, & Juri Ayub, 2015). BVMOs
gained attention in the field of biocatalysis, because several
representatives accept a very wide range of substrates, and catalysis
often occurs chemo‐, regio‐, and stereoselectively (Leisch, Morley, &
Lau, 2011). The BV reaction mechanism commences with a nucleo-
philic attack of the peroxide on the carbonyl carbon. In BVMOs, the
catalytic entity is a peroxyflavin, generated from the reaction of
molecular oxygen with reduced flavin adenine dinucleotide (FAD),
which in turn received the electrons from NADPH. After the addition
step, the so‐called “Criegee‐intermediate” rearranges, and generally,
the carbonyl‐adjacent carbon that is better at stabilizing a positive
charge migrates to the incorporated oxygen (Sheng, Ballou, & Massey,
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2001). Enzymes can violate this “migratory aptitude” by binding the
substrate such that the required antiperiplanar conformation of the
canonically migrating bond is prevented, thus forcing the arrangement
to the “abnormal” BV product (Li et al., 2018). An additional advantage
of biocatalysis is the use of O2 as the oxidant, in contrast to the
requirement of stoichiometric amounts of a peroxide reactant in the
chemical reaction. This circumvents the peril of highly explosive
concentrated peracids, as well as the generation of hazardous waste
(Kamerbeek, Janssen, van Berkel, & Fraaije, 2003). Since these
problems are above all relevant for industrial processes, biocatalytic
alternatives should also be applicable at this scale.
One major hurdle to that end has efficiently been addressed in
recent years: the prohibitively expensive nicotinamide cofactor
consumed in the reaction is now routinely recycled by using whole‐
cell systems, or by using a redox partner enzyme (Torres Pazmiño,
Winkler, Glieder, & Fraaije, 2010). Various alternatives have been
described, making for example use of dehydrogenases that regener-
ate NADPH from NADP+, either at the expense of a cheap sacrificial
substrate, or with concurrent oxidation of a cascade reaction‐
participating substrate (Bučko et al., 2016). Molecular fusions of
the recycling enzymes facilitate handling and seldom affect enzyme
activity (Aalbers & Fraaije, 2017; Mourelle‐Insua, Aalbers, Lavandera,
Gotor‐Fernández, & Fraaije, 2019).
A remaining issue, however, is the poor stability of most BVMOs.
In an industrial process, high temperatures and the use of cosolvents
often are a prerequisite, or greatly increase efficiency or suitability.
These conditions are incompatible with many BVMOs, which can
inactivate within minutes, even in the buffer and at room
temperature. The only truly thermostable BVMO, phenylacetone
monooxygenase (PAMO) from Thermobifida fusca, unfortunately
presents a strictly limited substrate scope and poor selectivities
(Fraaije et al., 2004). PAMO was the first BVMO whose crystal
structure was solved (Malito, Alfieri, Fraaije, & Mattevi, 2004), and
despite intensive subsequent protein engineering (Bocola et al.,
2005; Dudek et al., 2014; Parra, Acevedo, & Reetz, 2015; Reetz &
Wu, 2009), catalytic efficiencies with most substrates remain too low
to achieve industrially required productivities. One of the most
important BV transformation, the conversion of cyclohexanone to ε‐
caprolactone, a precursor to nylon‐6, is particularly difficult to
achieve with PAMO. There is, however, a subgroup of BVMOs that is
highly active on this substrate, the so‐called cyclohexanone mono-
oxygenases (CHMOs). In fact, the first BVMO isolated was a CHMO
stemming from Acinetobacter sp. NCIMB 9871 (AcCHMO). Although
this enzyme is particularly unstable, it has become a prototype in
BVMO research because of its high activities and substrate
promiscuity, while often showing excellent selectivities.
A few studies have been reported in which AcCHMO's robustness
could be improved: two studies introduced disulfide bridges (Schmidt,
Genz, Balke, & Bornscheuer, 2015; van Beek, Wijma, Fromont,
Janssen, & Fraaije, 2014), and the best mutants displayed an increase
in the protein's melting temperature (Tm), defined as the midpoint of
the thermal denaturation curve, of 5 and 6°C, respectively. In an
attempt to target the enzyme's oxidative stability, the third study
introduced point mutations at sulfur‐containing residues (Opperman &
Reetz, 2010). While not measuring Tm, the authors reported on the
temperature at which 50% of activity remained after incubation at
various temperatures, which shifted by 6.8°C in the best mutant.
When a recent study combined the most beneficial of these reported
mutations, no Tm was reported, but it was found that none of
thermostabilized mutants could outperform the wild‐type enzyme in
terms of ε‐caprolactone production (Engel, Mthethwa, Opperman, &
Kara, 2019). The authors attribute this result to the impaired catalytic
parameters of the mutants. Although some of these studies have also
quantitatively measured the mutants’ long‐term stability, a comparison
of these results in terms of absolute values (Balke, Beier, &
Bornscheuer, 2018) must be treated very cautiously: often, data is
not available for the same temperature and as the assays are not
standardized, the results may be influenced by variations in the
particular measurement (Goncalves et al., 2017). Discrepancies across
various studies, which can span over a few orders of magnitude, may
furthermore be a result of the strong influence of additives on the
stability of these enzymes (Goncalves et al., 2017). Regardless of the
ultimate origin, it is clear that previous thermostability engineering
efforts were only met with very limited success. A contributing factor
to this outcome likely is the unavailability of a crystal structure of
AcCHMO.
Recently, structures became available of two close homologs of
AcCHMO: RhCHMO from Rhodococcus sp. HI‐31 (Mirza et al., 2009),
and TmCHMO from Thermocrispum municipale (Romero, Castellanos,
Mattevi, & Fraaije, 2016). The various structures of RhCHMO
advanced mechanistical BVMO research, as it allowed intricate
insight into both structural and catalytic features of CHMOs (Mirza
et al., 2009; Yachnin et al., 2014; Yachnin, Sprules, McEvoy, Lau, &
Berghuis, 2012). TmCHMO, on the other hand, can be seen as a big
progression toward applicable CHMOs, and with a Tm of 48 °C, it is
considerably more stable than both AcCHMO and RhCHMO
(Romero et al., 2016). Yet, TmCHMO also shows a significantly
lower activity on cyclohexanone, with a kcat of 2 s
−1 being
approximately five times slower than that of the two homologs.
Even lower activities are found for PockeMO, another recently
described thermotolerant BVMO (Fürst et al., 2017). Because
RhCHMO remains a prototype in BVMO research, and its substrate
spectrum is highly similar to the by far best‐studied BVMO AcCHMO,
we attempted to engineer RhCHMO toward increased thermostability.
To that end, we applied our previously described framework for rapid
enzyme stabilization by computational libraries (FRESCO; Wijma et al.,
2014; Wijma, Fürst, & Janssen, 2018). This method uses two
independent algorithms to calculate the difference in folding free
energy, ΔΔGFold, between a wild‐type structure and a single point
mutant. After an in silico screening step supported by molecular
dynamics simulations, selected mutants are expressed and tested for
improved stability, and successful hits are combined to a final
stabilized mutant. So far, we applied the FRESCO procedure to five
enzymes, and achieved considerable improvements, with Tm increases
up to 35°C (Arabnejad et al., 2017; Floor et al., 2014; Martin, Ovalle
Maqueo, Wijma, & Fraaije, 2018; Wijma et al., 2014; Wu et al., 2016).
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Here we describe the results gained by applying FRESCO to
RhCHMO, where we could increase the Tm by up to 15°C in the most
stable mutant. Although numerous stabilizing point mutations were
encountered and confirmed the high success rate of the computational
predictions, several complications needed to be overcome: many stability
increases were small and not additive upon the combination, and some
mutations caused insoluble or inactive enzymes. Besides investigating
potential causes of these effects, we also devised a novel methodology to
easily create random combinatorial mutant libraries, which aided in
obtaining the most stable variant.
2 | MATERIALS AND METHODS
2.1 | General
All chemical reagents were purchased from Sigma‐Aldrich or TCI
Europe, unless otherwise stated. Oligonucleotide primers were
synthesized by Sigma‐Aldrich (Haverhill, UK) or Eurofins Scientific
(Ebersberg, Germany). DNA sequencing was performed by GATC
(Konstanz, Germany) and Eurofins Scientific.
2.2 | Computational methods
The computational predictions by FRESCO were carried out by
following the detailed protocol described in Wijma et al. (2018).
2.2.1 | Structure preparation
Using the YASARA software (Krieger & Vriend, 2014), the RhCHMO
structure from PDB ID 4RG3 was prepared by adding hydrogens and
removing alternative side chain configurations, buffer and active site
ligand molecules. After using a YASARA script to identify residues
with less than 5 Å distance from the active‐site ligand, the FAD and
NADP+ cofactor, the remaining residues were subjected to Rosetta‐
DDG (Kellogg, Leaver‐Fay, & Baker, 2011) and FoldX (Schymkowitz
et al., 2005).
2.2.2 | Single mutant predictions
Rosetta's ddg_monomer version 2015.25.57927 was run using the
“row 3 protocol” and these settings: ddg::weight_file soft_rep_design,
ddg::iterations 50, ddg::local_opt_only true, ddg::min_cst false,
ddg::mean true, ddg::min false, ddg::sc_min_only false, ddg::ramp_re-
pulsive false, ddg::opt_radius 8.0, ddg::dump_pdbs false.
FoldX version 3.0b6 was used in the BuildModel mode with these
settings: Temperature = 298 K, pH = 7, IonStrength = 0.05, move-
Neighbours = true, VdWDesign = 2, numberOfRuns = 5.
2.2.3 | MD screening
The ΔΔGFold energy predictions of both programs were sorted and all
mutations with a predicted energy of <−5 kJmol‐1 were subjected to
molecular dynamics (MD) simulations. For each mutant, five MD
simulations with a random initial velocity seed were performed using a
YASARA script employing Yamber3 as the force field. The system was
warmed up from 0 to 298K in 30 ps, followed by 20ps equilibration, and
a subsequent production run of 50 ps, where snapshots were sampled
every 5 ps.
2.2.4 | Visual inspection
All mutants were visually inspected using YASARA with a custom
plugin (Wijma et al., 2018). The average structure of each MD
simulation was superimposed and the structure with the most
notable differences eliminated, while the remaining four served as
the basis for the visual screening of flexibility alteration. For
experimental screening, only those were chosen, which showed no
unfavorable hydrogen‐bonding alterations, no drastic hydrophobic
surface exposure, and no increased local or overall flexibility.
YASARA was also used to create the structural figures, except for
Figure S10, which was created using the adaptive Poisson–Boltz-
mann solver (APBS) web server (Jurrus et al., 2018) with standard
settings and visualizing the results using Chimera 1.10.2.
2.3 | Molecular biology methods
The experimental procedure of screening targeted libraries was
carried out by following the detailed protocol described in Fürst,
Martin, Lončar, and Fraaije (2018).
2.3.1 | QuikChange mutagenesis
High throughput mutagenesis was conducted using a modified
QuikChange protocol (Liu & Naismith, 2008) for which the primers
were designed using AAscan (Sun et al., 2013). PCRs were conducted
in 96‐well thin‐walled plates (Bio‐Rad) using the Pfu Ultra II Hotstart
Master Mix (Agilent). As template served the native sequence of the
Rhodococcus sp. HI‐31 gene (genbank accession number BAH56677)
cloned into the previously described (Torres Pazmiño et al., 2009)
pCRE vector, a pBAD‐NK derivative where the monooxygenase is N‐
terminally fused to a 6×‐His‐tagged, thermostable phosphite dehy-
drogenase (PTDH). The PCR program was 95°C–3min; (95°C–30 s;
55°C–30 s; 72°C–3min) x 26; 72 °C–12min. Subsequently, 10 U
DpnI were added to each well to digest the template plasmid. After at
least 4 hr reaction, 3.5 µl were transformed in chemically competent
E. coli NEB10beta cells via 30 s heat shock at 42°C. Plating was
conducted on 24‐well plates containing LB‐agar with ampicillin. A
single colony was picked and grown on a 96‐well LB‐agar plate and
sent for plasmid extraction and sequencing to Eurofins Genomics.
2.3.2 | Randomly shuffled library creation
The first library, which used the M4 mutant as a template, was based on
the multichange isothermal mutagenesis (MISO) method (Mitchell et al.,
2013), in which one Gibson‐assembles overlapping PCR fragments
amplified using mutated primers. As seven mutations were to be
randomized and two targeted the same residue (E91K and E91Q), our
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library size was 25 ×3 =96 possible combinations. We designed over-
lapping primers according to MISO, but to randomize, we performed the
PCR with an oligonucleotide mix, combining a wild‐type sequence‐
containing primer with a mutation‐containing primer, or two, in case of
E91. We assembled the resulting fragment mix to full plasmids by Gibson
cloning and analyzed 95 clones of the transformed library by DNA
sequencing. The clones were mixed and each targeted position was either
wild‐type or mutant, but in one case the ratio was strongly biased toward
wild‐type (84%), and position 91 favored one of the mutations (60%;
Figure S4A). This bias can originate from the PCR with mixed primers,
where template‐binding may be altered by the mutation. Additionally,
efficiency variations can occur in the assembly, where sequence‐
dependent secondary structures impair fragment annealing. Although
we attempted to mitigate these effects through silent mutations in the
wild‐type primers and the use of secondary structure prediction software
(Geneious), this precaution proved to be only partly successful.
For the second library, the M2 mutant served as a template, and
mutations D10Y and D119R were excluded. To create the resulting
library of again 96 possibilities without bias, we first created a plasmid
with six mutations by MISO. Then, PCRs were performed with primers
that generated fragments where the mutated site lies centrally. To
randomize, we used a template mix combining the wild‐type plasmid and
the 6x mutated plasmid (plus the single mutant plasmid with the third
mutation for the fragment with position 91). With both the primer
binding site and the assembly overlap now occurring at areas remote
from the mutation, we expected to avoid bias. We sequenced 48 clones
of the assembled and transformed library and performed a χ2 test on the
data (Microsoft Office Excel), using an equal 1:1 distribution as expected
value range. We also sequenced a culture of a mix of all colonies by
inoculating a single 5ml culture tube with all of the 96 clones. The mixed
signals in the electropherogram were analyzed using Geneious.
2.4 | Biochemical methods
2.4.1 | Expression and cell‐free extract preparation
NEB10beta cells transformed with the pCRE‐RhCHMO construct
were grown overnight in 200 µl LBamp with vigorous shaking at 37°C
in two identical 96‐well plate. Eight‐hundred microliters of TBamp
were added and the plates were shifted to 24°C with vigorous
shaking. After approximately 36 hr, an OD600 of approximately 20
was reached and the cells were harvested by centrifugation. Cells
were resuspended in 50mM Tris/HCl pH 7.5 buffer containing
10mM MgCl2, 0.5 mg/ml DNase I (NEB), and 1mg/ml lysozyme
(Sigma‐Aldrich). After 30min incubation at 20°C, the cells were
shock frozen in liquid N2 and thawed in a water bath. Cell debris was
removed by centrifugation at 4°C and 2,250g for 45min.
2.4.2 | Protein purification
The cell‐free extract (CFE) of the two identical plates was combined
and subjected to affinity chromatography using 100 µl Ni2+‐Sephar-
ose (GE Healthcare) in a 96‐well filter plate. The Ni2+ resin was
allowed to incubate with the CFE for 1 hr, before removing the flow‐
through by centrifugation. The resin was washed with 200 µl 50mM
Tris/HCl pH 7.5 and the same buffer with additionally 5mM
imidazole added. The pure protein was then eluted by adding
100 µl of 50mM Tris/HCl pH 7.5 + 500mM imidazole. Desalting was
performed by using a PD MultiTrap G‐25 96‐well desalting plate (GE
Healthcare) according to manufacturer's instructions.
2.4.3 | Thermostability screen
The purified protein's Tm was determined by the ThermoFAD method
(Forneris, Orru, Bonivento, Chiarelli, & Mattevi, 2009). Twenty
microliters of the desalted protein solution was transferred to a
qPCR plate (iQ, Bio‐Rad) and subjected to a melt curve program in a
qPCR machine (Touch Thermal Cycler; Bio‐Rad), which ramped the
temperature from 20 to 99°C in 0.5°C increments after 10 s
incubation and a fluorescent read step. For excitation, a 450 to
490 nm filter was used and for emission, a 515 to 530 nm filter.
2.4.4 | Enzyme kinetics
To determine the kinetic constants, reactions of RhCHMO with
cyclohexanone and NADPH were followed spectrophotometrically
(V‐660; Jasco) at 340 nm (ɛ340 = 6.22mM‐1 cm‐1). The 200 µl reaction
mixture contained 50mM Tris/HCl pH 7.5, 0.05 µM RhCHMO,
100 µM NADPH, and 0 to 500 µM substrate. The mix was quickly
transferred to a 0.1 ml quartz cuvette after addition of NADPH and
the absorbance at 340 nm was measured for 45 s. The kinetic
constants were calculated by fitting the data to the Michaelis‐
Menten equation using the GraphPad Prism 6.
2.4.5 | Temperature optimum
The temperature optimum was determined by following the same
procedure as for the enzyme kinetics determination, but using always
100 µM of cyclohexanone and varying the temperature. One hundred
and eighty microliters of the enzyme‐substrate mix was incubated at the
specified temperature for 2min, to allow the solution's temperature to
equilibrate. Addition of 20 µl NADPH then started the reaction, and the
mix was transferred to a 0.1ml quartz cuvette, which was placed in the
preheated sample holder of the spectrophotometer.
2.4.6 | Stability over time
The enzyme was incubated at the specified temperature, after which
a sample was taken and the residual activity determined by following
the same procedure as specified above.
3 | RESULTS AND DISCUSSION
3.1 | In silico predictions
There are five different crystal structures of RhCHMO in the protein
data bank (PDB), all of which have been suggested to represent a
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distinct conformation adopted by the enzyme throughout its catalytic
mechanism. Although all structures contain both the FAD and the
NADP cofactor, previous computational analysis of RhCHMO was
based on the “closed” structure (PDB ID 3GWD), because it was
assumed to represent the catalytically more relevant conformation in
which the substrate is converted (Polyak, Reetz, & Thiel, 2012).
While the “open” structure (3GWF) was proposed to represent the
enzyme in the ligand‐free form, the lack of electron density for a
large loop on the protein's surface already impedes a reliable
computational analysis (Mirza et al., 2009). This so‐called control‐
loop, stretching from residue 488 to 504, is also lacking in the
“rotated” (3UCL; Yachnin et al., 2012) and “loose” (4RG4; Yachnin
et al., 2014) conformations.
For the FRESCO calculations, we used the fifth, “tight”
RhCHMO structure (4RG3; Yachnin et al., 2014), which presents
a “closed” conformation with an ordered control‐loop, contains a
ligand in the active site, and is the structure with the highest
resolution. We applied the in silico protocols as previously
described in detail (Wijma et al., 2018), which predict stabilizing
mutations by applying the Rosetta‐DDG (Kellogg et al., 2011) and
FoldX (Guerois, Nielsen, & Serrano, 2002) algorithms in combina-
tion with MD simulations. Instead of performing the calculations
on all of the 10,260 possible point mutants (19 × 540 residues),
mutagenesis of catalytically relevant positions was avoided by
excluding residues in a distance smaller than 5 Å from the active
site. As BVMOs stably bind to FAD and NADP+ (Sheng et al.,
2001), we also had to exclude residues in the vicinity of these two
cofactors (Figure S1). Although the preservation of cofactor
affinity is an obvious aim, the main reason is that the Rosetta
and FoldX algorithms are not parameterized to work with
cofactors. Any calculations for these residues would, therefore,
be unreliable. After ranking the calculations of the remaining
8,350 mutations by energy (Figure S1), the 853 variants that
showed a ΔΔGFold ≤ −5 kJ mol−1 underwent short MD simulations,
which included the cofactors. The generated in silico structures
were then visually inspected. After discarding chemically unrea-
sonable mutations and those where MD simulations suggested an
increase in flexibility of the protein, we chose initially 114 point
mutations for experimental verification (Figures S1, 1).
3.2 | Stability determination of point mutants
We performed the experimental stabilization procedure (see Figure
S1 for an overview of the workflow) from DNA mutagenesis to Tm
measurements of purified enzymes following a protocol recently
published as a step‐by‐step description (Fürst et al., 2018). A 96‐well
format was maintained throughout nearly the entire procedure. First,
we exchanged the targeted codon using the QuikChange method on
a plasmid harboring the RhCHMO gene fused to an NADPH‐
recycling PTDH‐encoding gene. After transformation into E. coli
NEB 10 beta cells, we expressed the proteins on a 2ml scale. The
CFE of the lysed cells was then subjected to affinity chromatography
that took advantage of an N‐terminal 6×‐histidine tag. The Tm of the
purified protein was determined in a flavin‐fluorescence‐exploiting
thermal shift assay called ThermoFAD (Forneris et al., 2009). As it is
convenient to avoid full purification and perform Tm determinations
using CFEs, but the results may vary significantly, we measured Tms
for both the CFE and the purified proteins. With a coefficient of
determination R2 of only 0.68 (Figure S2), we deemed the Tm of
RhCHMO to apparently be too strongly influenced by the soluble
cellular components in the CFE and decided for Tm measurements to
rely on purified proteins only.
Out of 114 of the RhCHMO single mutants initially selected from
the FRESCO calculations, 18 repeatedly gave no detectable
ThermoFAD signal, likely caused by insufficient expression of soluble
protein and/or a lack of FAD incorporation. Although BVMOs with
lowered cofactor affinity can be reconstituted to the holoenzyme by
adding an excess of FAD during purification, this is an unattractive
feature for application and no reconstitution attempt was made. Of
the remaining 96 mutants, 34 had a decreasing effect, 13 had no
effect and 50 had an increasing effect on Tm (Figure 1a). Although
this success rate compares favorably with previous FRESCO
stabilizations, where typically 20 to 40% were found stabilizing
(Arabnejad et al., 2017; Floor et al., 2014; Wijma et al., 2014), most of
F IGURE 1 Tm increase of RhCHMO for the first (a) and second (b) set of point mutants. Stabilizing mutations with a Tm increase of at least
1°C are shaded pink, stabilizing mutations not considered for mutant combinations are indicated by a striped pattern. RhCHMO, cyclohexanone
monooxygenase from Rhodococcus sp. HI‐31 [Color figure can be viewed at wileyonlinelibrary.com]
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the Tm improvements we found for RhCHMO were very small. When
we selected 13 mutations with a ΔTm of at least 1°C and produced
the proteins on a larger scale for verification, we were able to
confirm the stabilizing effect for all but one mutation (E293A). The
remaining 12 were subjected to the next step in the FRESCO
procedure, the combination of mutations in a multiple mutant.
3.3 | Mutant combination libraries
Initially, we combined the most stabilizing mutations by successive
rounds of QuikChange. When we tested the mutant proteins,
however, we noticed that the Tm increases were not additive and
that the addition of one mutation (A11M) caused expression of an
insoluble protein. The most stable mutant with a Tm increase of 6.3°C
was the 4x mutant Q409P/N431Y/A115V/A455V (M4). As we also
observed unsatisfactory results when adding mutations in another
order, we decided to change strategy and devised a more systematic
method.
We previously created a combinatorial library of wild‐type and
mutant residues by golden gate shuffling using synthetic genes
(Martin et al., 2018). To explore a method that avoids DNA synthesis,
we now applied a PCR‐ and Gibson assembly‐based method. We
decided to use the M4 mutant as a starting point and to exclude the
A11M mutation, while randomizing the remaining seven mutations.
As two mutations targeted position E91, the library size was 96
(25 × 3). Initially, we created the library using an altered method
described for the simultaneous mutation of several positions on a
plasmid (Mitchell et al., 2013; Figure S3). Details of our adapted
procedure, which is based on the direct generation of mixed wild‐
type and mutated PCR fragments and Gibson assembly, are
described in the experimental section. DNA sequencing of 95 clones
of the library confirmed a shuffled library but revealed an uneven
distribution of wild‐type and mutant in some cases (Figure S4A).
When we expressed three 96‐well plates of individual clones (to
achieve ~95% library coverage if there was no bias) and measured
the purified protein's Tm, we found only a few hits with marginally
increased stability (data not shown). This seemed to suggest that our
starting point was a dead‐end combination that had reached a
thermostability plateau. Noticing also the absence of a signal in
approximately 70% of the clones, we cross‐referenced the
results with their sequences. We found that the mutants giving a
signal always had the wild‐type residue at two positions (D10Y and
D119R), which we thus deemed as incompatible for combinations
(Figure S4B).
We decided to create a second library without these mutations
and tried to escape the stability dead‐end by randomizing A115V and
A455V, using the double mutant Q409P/N431Y (M2) as the new
template. To furthermore create the resulting library of again 96
possibilities without bias, we also adapted the method for generating
the library (Figure 2). We now first created a fully mutated plasmid
and then generated mixed wild‐type and mutated PCR fragments
with primers remote from the mutated site. We sequenced 48 clones
of the assembled and transformed library and again found successful
randomization. Furthermore, a χ2 test on the data found no
significant deviation from the expected 50% (or 33% in the case of
position 91) ratio (Figure S5; Table S1). We also sequenced a culture
of a mix of all colonies, and as the mixed signals in the
electropherogram reflected the same distribution, we conclude that
this suffices in verifying such libraries quickly (Figure S6).
We then produced the proteins from three 96‐well plates of
individual clones and measured Tm. Although we found a much higher
signal rate (81% of all clones), again no combination of mutations
increased the thermostability of RhCHMO to a large extent (data not
shown). At this point, the strongest increase in Tm with respect to the
F IGURE 2 Method to create the second shuffled library without bias. The wild‐type plasmid was used as a template in PCRs with mutated
primers to generate DNA fragments containing two mutations on each end. The purified fragments were assembled by Gibson cloning to obtain
a plasmid with all mutations. An equal mix of this mutated and the wild‐type plasmid was used in the next round of PCR where primers were
used that bound outside the mutated region to generate a mix of fragments with and without mutations. Upon Gibson assembly of this mix, the
shuffled library was obtained. PCR, polymerase chain reaction [Color figure can be viewed at wileyonlinelibrary.com]
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wild‐type was 7.3°C found for a 7x mutant (M7), only 1°C more
stable than the M4 mutant (Figure 3).
3.4 | Final stabilization mutations
Acknowledging the fact that we seemed to have found the largest
possible Tm increase achievable with our initially selected mutations
but being unsatisfied with the result, we decided to test an additional
small set of point mutations. Revisiting the computationally predicted
list of single mutants, we, therefore, selected 14 more mutations to
be tested experimentally. Following the same procedure as before,
we found no signal for four, a destabilizing or no effect for five, and a
significant increase in Tm for three mutations (Figure 1b). At this
point, an independent study found indications for an implication of
one of the stabilizing residues, located in the substrate tunnel, on the
substrate scope of a related CHMO (Fürst, Romero et al., 2018). For
this reason, we excluded this mutation (L509F) from further
combination. The other two mutations were directly added to our
most stable mutant M7. Gratifyingly, we found a larger than additive
effect on Tm: while the single mutants, D95H and Q191M increased
the Tm by 4.5 and 1.5°C, respectively, addition to M7 increased the
Tm by 6.4 and 3.2 °C, respectively. When we added both mutations,
the effect remained additive in the resulting mutant M9, which
showed a Tm increase of 15°C with respect to wild‐type.
As the FRESCO protocol foresees to exclude residues in a 5Å radius
from the active site, changes in activity are rarely observed in stabilized
mutants, with the exception of a common upshift of the temperature
optimum. There are indications, however, that the activity of BVMOs is
not purely determined by active‐site residues (Fürst, Romero et al.,
2018). When we checked the most stable mutants for activity on the
native cyclohexanone substrate, we found a highly diminished activity
for the M9 mutant, but not for M7. We then looked at the activity of
the 8x mutant with the second highest Tm (49°C), and found this mutant
(M8B) to be highly active again. In comparison to M9, M8B only lacks
mutation Q191M, which was thus identified as the activity‐abolishing
mutation. We also determined the temperature optimum of the two
enzyme variants and found a shift that was very much in line with their
melting temperatures (Figure 4a). The kinetic constants were then
measured at standard conditions, and we found a kcat of 4.9 s
−1 for the
mutant compared to 9.2 s−1 for the wild‐type (Figure S7; Table 1). The
high affinity for cyclohexanone was retained in the mutant, and the Km
could only be estimated to be <1 µM for both wild‐type and mutant
(Table 1). To estimate the monooxygenases‐inherent degree to which
NADPH oxidation is uncoupled from substrate oxygenation, we also
measured rates in the absence of substrate. We found a very low
uncoupling rate of 0.05 s−1 in the wild‐type, which only slightly
increased in the mutant (0.13 s−1).
Previous FRESCO projects also demonstrated that the
proteins’ Tm increase was accompanied by long‐term stability,
that is longer retention of activity over time. To determine this
characteristic for our most stable RhCHMO mutants as well, we
measured the residual activity of the wild‐type, the M8B, and the
intermediate M7 mutant after incubation at 30 and 37 °C (Figure
4b; Figure S8). These measurements demonstrated a strong
correlation between Tm and stability over time, as the enzyme's
half‐life of activity at 30°C was improved 33‐fold from 22 min in
the wild‐type to 12.3 hr. For the M7 mutant, we measured a half‐
life of approximately 5 hr, which lies approximately in the middle
F IGURE 3 Tm increase of RhCHMO by a combination of mutations to a highly stabilized multiple mutant. RhCHMO, cyclohexanone
monooxygenase from Rhodococcus sp HI‐31 [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 4 Comparison of the stabilized mutants with wild‐type RhCHMO. (a) Temperature optimum of wild‐type RhCHMO and M8B
mutant. (b) Activity over time upon incubation at 30°C. (c) Comparison of Tm and half‐life. RhCHMO, cyclohexanone monooxygenase from
Rhodococcus sp. [Color figure can be viewed at wileyonlinelibrary.com]
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between wild‐type and M8B mutant, as does the Tm of this
variant (Figure 4c). Similarly, the half‐life at 37°C increased from
8.6 min in the wild‐type to 135 min in the M8B mutant (Figure
S8). We thus again demonstrated the high correlation between a
protein's unfolding temperature and its stability over time.
Considering the largely retained catalytic properties (Figure S7)
and the high increase in stability over time, the RhCHMO M8B
mutant is a much more suitable biocatalyst for application than
both its wild‐type template and the very similar AcCHMO
(Table 1).
3.5 | Structural analysis of mutations
To rationalize some of the effects observed by the mutations, we
analyzed the location and environment of the respective residues in
the protein's structure.
The two most stabilizing mutations of the first set, combined in the
M2 mutant, were N431Y and Q409P, which are located very closely
together (Figure 5a). For the N431Y mutation, a combination of
improved protein packing and hydrogen‐bonding network seems to
occur: in the wild‐type structure, the asparagine fringes a cavity, which
is filled by the bulky tyrosine in the mutant. Furthermore, the carbonyl
of wild‐type N431 is unable to hydrogen bond and this is prevented in
the mutant, where the van derWaals interactions with the nearby V505
TABLE 1 Kinetic and stability properties of CHMOs compared
CHMO variant Tm kcat Km Reference
AcCHMO 37.0°C 6 s−1 <4 µM Romero et al. (2016)
TmCHMO 48.0°C 2 s−1 <1 µM Romero et al. (2016)
RhCHMO 36.0°C 9.2 s−1 <1 µM This study
RhCHMO M8B 48.8°C 4.9 s−1 <1 µM This study
Abbreviation: CHMOs, cyclohexanone monooxygenases.
F IGURE 5 Mutations introduced in RhCHMO to increase thermostability. The crystal structure of RhCHMO (PDB ID 4RG3) shown in
cartoon representation and colored yellow, green and cyan for FAD, NADP, and helical domain, respectively. FAD is shown in yellow and
NADP+ as green sticks. (a–c) show the close up view of important residues, where the computationally predicted mutations are superimposed
and shown as sticks with pink carbons. Alpha carbons are indicated by balls, hydrogen bonds as yellow dashed lines, and water molecules from
the crystal structures as red balls. In (a) a transparent sphere indicates a cavity observed in the wild‐type, which is filled by the tyrosine
mutation. (d) shows the overall protein structure and all mutations experimentally shown to be stabilizing are shown as balls in shades of red
indicating the degree of stabilization. FAD, flavin adenine dinucleotide; RhCHMO, cyclohexanone monooxygenase from Rhodococcus sp HI‐31
[Color figure can be viewed at wileyonlinelibrary.com]
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occur instead. The asparagine's amine group coordinates two water
molecules, one of which is replaced by the tyrosine's hydroxyl group in
the mutant, and which constitutes the link to Q409. For this residue, the
effect of the mutation stems from elsewhere: Q409 is located on a
surface‐exposed loop and, unlike proline, can hydrogen bond to the
solvent waters. Analysis of the MD simulations indicates that the more
rigid torsion angles forced upon the backbone by proline decrease the
flexibility of the loop and nearby regions, which likely is the cause of the
improved stability (Figure S9).
D95 is located at the center of a negatively charged surface patch
(Figure S10A; Figure 5B). As no obvious hydrogen‐bonding impair-
ments or flexibility alterations are observed in the histidine mutant,
the stabilizing effect might be related to the charge change. One
possibility is that the mutated residue forms a salt bridge, assuming
that the solvent‐exposed histidine surrounded by acidic residues is
mostly in the protonated form. Such an interaction is, however, not
observed in the predicted structure. The stabilizing effect could
therefore simply result from preventing a thermodynamically
unfavorable clustering of anionic residues (Figure S10).
The activity‐abolishing effect of mutation Q191M could be
related to a hydrogen bond that this residue establishes with a
strictly conserved glycine that is part of the NADP binding Rossmann
fold motif (Figure 5c). Although this interaction occurs through
Q191's backbone amine, even small perturbations of the backbone
entailed by other side chains may be enough to critically impair
folding and/or NADP binding. It is also noteworthy that Q191 is part
of the NADP domain, but connects to the BVMO's so‐called helical
domain through a hydrogen bond of the amide with S214. The
residue thus might also be critical for domain orientation and/or
movement, which may occur in these proteins during catalysis (Fürst,
Fiorentini, & Fraaije, 2019). Performing a multiple sequence align-
ment, we also found Q191 to be highly conserved in BVMOs, further
suggesting an important functional role (Figure S11).
Interestingly the final stabilized mutant contains most mutations
in the FAD domain (Figure 5d). While some mutations were found in
the NADP domain in the single mutant screen, they proved
incompatible in the combination mutants. Also one of the two
mutations in the helical domain was discarded in this step.
The fact that we found a thermostability plateau in the
combinations of the first single mutant set let us to believe that we
were missing out on stabilizing an early‐unfolding region. If such a
region triggers irreversible unfolding at a fixed temperature, this
could mask a stabilization towards higher temperatures in another
region. This hypothesis is also substantiated by the fact that the
mutations of Set 2 gave a more than additive effect. Possibly, these
mutations prevented early‐unfolding, thereby unmasking the less
than additive effects observed for the previous mutants.
4 | CONCLUSIONS
CHMO has been a frequent target of protein engineering, despite its
complex catalytic mechanism: to overcome the challenge of
coordinating oxygen, two cofactors, and the organic substrate, these
enzymes employ protein domain and loop movements as well as
cofactor rearrangement (Fürst et al., 2019). This hampers many
computational design approaches including the here applied FRESCO
predictions, as molecular dynamics simulations are unable to cover the
timescales of large protein motions. As FRESCO's core algorithms are
restricted to the proteinogenic component of the enzyme, the cofactor‐
dependency was an additional limitation and required us to exclude
approximately 19% of the enzyme's residues from the calculations. Our
subsequent screening confirmed the reliability of those predictions,
however, with nearly half of the tested mutations exhibiting a stabilizing
effect. An innovative shuffled library design method then aided in
identifying the most stable mutant. The stabilizing effects of the here‐
identified mutations were context‐dependent and we found that the full
potential of initially non‐additive mutations can emerge after stabilizing
other protein regions. With 49°C, our best mutant shows a slightly
higher Tm than a recently discovered naturally thermotolerant CHMO
(Romero et al., 2016) while performing catalysis at a roughly 2.5x higher
maximum rate. Our mutant also shows a vastly extended lifetime, and
our results confirm previous findings that Tm and half‐life are strongly
correlated (Figure 4c). Our observations suggest a proportional
dependency of the two parameters when considering variants of the
same enzyme, but not necessarily when comparing different enzymes.
In analogy, comparison with literature is straightforward for Tm values,
but difficult for long‐term stability data. Although such comparisons
have been made (Balke et al., 2018), the vast discrepancy across studies
is exemplified in the literature data on wild‐type AcCHMO stability
spanning three orders of magnitude (Goncalves et al., 2017). Until a
single study reproducibly compares all available variants under the
same conditions, we believe that Tm values obtained by fluorescent shift
assays remain the most reliable and reproducible constant for a first
estimate. Total turnover numbers are also better comparable in
principal; however, they heavily depend on the reaction conditions,
whose optimization for a particular system is laborious as it requires the
careful adjustment of many parameters at once (Engler, Gruetzner,
Kandzia, & Marillonnet, 2009). As long as conditions are constant within
a single study, relative improvements, such as the here presented Tm
shift of 13°C and 30x extended half‐life are potentially the most robust
measure.
Whether or not this improvement is sufficient for application
remains to be seen. Even wild‐type AcCHMO has already been used
in industry (Doig et al., 2002), showing that the particular process
economics are not only dictated by enzyme stability, but also for
example on specific activity, substrate loading, downstream proces-
sing and product price (Tufvesson, Lima‐Ramos, Nordblad, &
Woodley, 2011). Thus, stabilized variants like the one presented
here contribute to shift biocatalysis from a niche technology to
broader application.
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